Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
preceded by desmosterol changes that would serve as a predictive safety biomarker for lenticular opacity
Vitamin B3
3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid sodium
Its primary mechanism is direct stimulation of β1 receptors of the sympathetic nervous system
Trametinib DMSO solvate - CAS# 1187431-43-1 Catalog No.:M10955-10 preceded by desmosterol changes thatTrametinib, also known as GSK1120212, is a n orally bioavailable inhibitor of mitogen activated protein kinase kinase (MEK MAPK ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in an inhibition of growth factor mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual specificity threonine tyrosine kinases often upregulated in various cancer cell
US$ 14.30
US$ 236.50
US$ 154.00
US$ 435.00
US$ 177.00
US$ 130.00
US$ 117.00
US$ 165.00